Cilomilast

From WikiMD.org
Jump to navigation Jump to search

Cilomilast

Cilomilast (pronounced as /si-lo-mi-last/) is a selective PDE4 inhibitor developed for treating respiratory disorders such as COPD and Asthma.

Etymology

The term 'Cilomilast' is derived from the systematic IUPAC name 'Cilomilast', which is an amalgamation of parts of the chemical name 'Cyclohexyl-N-(3,5-dichloropyridin-4-yl)-4-difluoromethoxy-N-methylbenzamide'.

Usage

Cilomilast is used primarily in the treatment of COPD. It works by reducing inflammation in the lungs, thereby improving airflow and reducing symptoms such as shortness of breath.

Related Terms

  • PDE4 inhibitor: A type of drug that blocks the action of phosphodiesterase 4, an enzyme involved in inflammatory responses.
  • COPD: A type of obstructive lung disease characterized by long-term breathing problems and poor airflow.
  • Asthma: A long-term inflammatory disease of the airways of the lungs.

See Also

  • Roflumilast: Another PDE4 inhibitor used in the treatment of COPD.
  • Bronchodilator: A substance that dilates the bronchi and bronchioles, decreasing resistance in the respiratory airway and increasing airflow to the lungs.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski